Shnyder S D, Hayes A J, Pringle J, Archer C W
Anatomy Unit, School of Molecular & Medical Biosciences, Cardiff, Wales, UK.
Br J Cancer. 1998 Sep;78(6):757-9. doi: 10.1038/bjc.1998.573.
The expression of the drug resistance (DR) mediators P-glycoprotein (P-gp) and the metallothioneins (MT) was assessed immunohistochemically in biopsy material from patients with high-grade malignant osteosarcoma (OS). No significant difference was found in survival rate between expressors of both P-gp and MT and non-expressors. Thus, it was concluded that lack of expression of these two drug resistance-related proteins does not appear to confer any advantage in terms of patient survival in osteosarcoma.
采用免疫组织化学方法,对高级别恶性骨肉瘤(OS)患者活检材料中耐药(DR)介质P-糖蛋白(P-gp)和金属硫蛋白(MT)的表达情况进行了评估。P-gp和MT的表达者与非表达者之间的生存率未发现显著差异。因此得出结论,在骨肉瘤患者生存方面,这两种耐药相关蛋白的缺失似乎并未带来任何优势。